☆ 4.2 Editorial Material

Severe persistent injection site reactions after subcutaneous 2′-O-methyl phosphorothioate oligonucleotide therapy for Duchenne muscular dystrophy

NEUROMUSCULAR DISORDERS (2018)

Get Full Text
Add to Collection

Journal

NEUROMUSCULAR DISORDERS
Volume 28, Issue 2, Pages 176-177

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2017.11.015

Keywords

Antisense oligonucleotide; Exon skipping; Subcutaneous injections; Morphea-like skin lesion; Duchenne muscular dystrophy

Categories

Clinical Neurology Neurosciences

Funding

  1. National Institute for Health Research [NF-SI-0515-10022] Funding Source: researchfish

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.